Adjunctive Pascolizumab in Rifampicin-Susceptible Pulmonary Tuberculosis: Proof-of-Concept, Partially-Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Trial
Nicholas I. Paton, Meera Gurumurthy, Qingshu Lu, Francesca Leek et autres
sg, gb, ph, my (code pays fourni par la source)